Cancer BiologybioRxivPreprint
YAP/TEAD drives treatment-induced adaptive immunosuppression in EGFR-mutant lung cancer
Meija Honkanen, Jonas Baumgarten, Nikol Dibus…·Kari J. Kurppa
This study shows that DTP cells in EGFR-mutant lung cancer drive immunosuppression through YAP/TEAD activity, and co-targeting YAP/TEAD improves EGFR TKI therapy efficacy.